Loading...
XSTO
ACARIX
Market cap30mUSD
Jun 16, Last price  
0.27SEK
1D
12.97%
1Q
-4.59%
Jan 2017
-98.27%
IPO
-97.53%
Name

Acarix AB

Chart & Performance

D1W1MN
P/E
—
P/S
46.31
EPS
—
Div Yield, %
—
Shrs. gr., 5y
89.32%
Rev. gr., 5y
27.28%
Revenues
6m
-0.62%
000638,0001,024,0001,857,0002,170,0003,760,0005,822,0006,241,0006,202,000
Net income
-66m
L-14.97%
-19,209,000-12,393,000-48,240,000-29,776,000-42,271,000-46,459,000-41,548,000-51,802,000-77,495,000-77,839,000-66,187,000
CFO
-63m
L-22.17%
-20,871,000-8,631,000-9,056,000-40,539,000-38,609,000-44,533,000-36,686,000-48,007,000-74,869,000-81,366,000-63,325,000
Earnings
Aug 20, 2025

Profile

Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases in Germany, Sweden, the Middle East, Switzerland, Austria, and internationally. The company offers CADScor System, a non-invasive and ultra-sensitive analytical device for the diagnosis of coronary artery disease. Acarix AB (publ) was founded in 2009 and is headquartered in Malmö, Sweden.
URL
https://acarix.com/
IPO date
Dec 19, 2016
Employees
20
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
6,202
-0.62%
6,241
7.20%
5,822
54.84%
Cost of revenue
72,575
83,794
82,297
Unusual Expense (Income)
NOPBT
(66,373)
(77,553)
(76,475)
NOPBT Margin
Operating Taxes
510
Tax Rate
NOPAT
(66,373)
(77,553)
(76,985)
Net income
(66,187)
-14.97%
(77,839)
0.44%
(77,495)
49.60%
Dividends
Dividend yield
Proceeds from repurchase of equity
86,980
106,443
69,335
BB yield
-37.63%
-118.03%
-87.16%
Debt
Debt current
251
Long-term debt
251
Deferred revenue
Other long-term liabilities
1,000
1,000
Net debt
(53,995)
(35,149)
(6,640)
Cash flow
Cash from operating activities
(63,325)
(81,366)
(74,869)
CAPEX
(920)
(151)
Cash from investing activities
(920)
(151)
Cash from financing activities
86,980
106,229
69,030
FCF
(74,316)
(56,083)
(33,488)
Balance
Cash
53,995
35,149
6,621
Long term investments
521
Excess cash
53,685
34,837
6,851
Stockholders' equity
(604,790)
(540,268)
(467,734)
Invested Capital
680,487
592,154
519,811
ROIC
ROCE
EV
Common stock shares outstanding
920,813
475,130
279,107
Price
0.25
32.24%
0.19
-33.40%
0.29
-67.32%
Market cap
231,124
156.29%
90,180
13.37%
79,546
-46.50%
EV
177,129
55,031
72,906
EBITDA
(63,083)
(74,465)
(73,438)
EV/EBITDA
Interest
267
132
163
Interest/NOPBT